Spelling suggestions: "subject:"immunophenotypic"" "subject:"immunophenotyping""
1 |
Immunophenotypic Analysis of Peripheral Blood and Synovial Fluid Lympocytes from Patients with Failed Hip ImplantsHurda, Ian 21 January 2013 (has links)
Metal-on-metal (MM) bearings have been considered as an alternative to conventional metal-on-polyethylene (MPE) bearings because of their lower volumetric wear, but concern exists due to potential metal hypersensitivity. Metal hypersensitivity reactions have been thought to be T cell-mediated delayed type hypersensitivity (DTH) reaction. However some of the MM periprosthetic tissues show the presence of B- and plasma cells, as well as massive fibrin exudation, which are not characteristic of a DTH reaction. Therefore, the exact nature of the hypersensitivity reaction(s) MM implants remains unclear. The present study aimed to compare the phenotypes of lymphocytes from the peripheral blood and synovial fluid of patients with failed MM and MPE implants, and from volunteers with no implant (peripheral blood only). Results in peripheral blood showed differences in the T-cell populations depending on the implant type. This included differences in the proportions of T-helper and T-cytotoxic cells, and T-cells expressing IFN-g. Results in synovial fluid showed a significant difference between MM and MPE groups for the B-cells. Both groups depicted a predominance of T-cell lymphocytes in synovial fluid and overall larger proportions of memory cells than in peripheral blood, but group sizes were rather small. Overall, T-cell cytokine expression (analyzed in peripheral blood only because of the limited number of synovial fluid samples) did not exhibit characteristics of a DTH reaction and the proportions of memory lymphocytes did not indicate activation of a specific subset in the MM group. Nevertheless, group sizes still remain to be increased.
|
2 |
Immunophenotypic Analysis of Peripheral Blood and Synovial Fluid Lympocytes from Patients with Failed Hip ImplantsHurda, Ian 21 January 2013 (has links)
Metal-on-metal (MM) bearings have been considered as an alternative to conventional metal-on-polyethylene (MPE) bearings because of their lower volumetric wear, but concern exists due to potential metal hypersensitivity. Metal hypersensitivity reactions have been thought to be T cell-mediated delayed type hypersensitivity (DTH) reaction. However some of the MM periprosthetic tissues show the presence of B- and plasma cells, as well as massive fibrin exudation, which are not characteristic of a DTH reaction. Therefore, the exact nature of the hypersensitivity reaction(s) MM implants remains unclear. The present study aimed to compare the phenotypes of lymphocytes from the peripheral blood and synovial fluid of patients with failed MM and MPE implants, and from volunteers with no implant (peripheral blood only). Results in peripheral blood showed differences in the T-cell populations depending on the implant type. This included differences in the proportions of T-helper and T-cytotoxic cells, and T-cells expressing IFN-g. Results in synovial fluid showed a significant difference between MM and MPE groups for the B-cells. Both groups depicted a predominance of T-cell lymphocytes in synovial fluid and overall larger proportions of memory cells than in peripheral blood, but group sizes were rather small. Overall, T-cell cytokine expression (analyzed in peripheral blood only because of the limited number of synovial fluid samples) did not exhibit characteristics of a DTH reaction and the proportions of memory lymphocytes did not indicate activation of a specific subset in the MM group. Nevertheless, group sizes still remain to be increased.
|
3 |
Immunophenotypic Analysis of Peripheral Blood and Synovial Fluid Lympocytes from Patients with Failed Hip ImplantsHurda, Ian January 2013 (has links)
Metal-on-metal (MM) bearings have been considered as an alternative to conventional metal-on-polyethylene (MPE) bearings because of their lower volumetric wear, but concern exists due to potential metal hypersensitivity. Metal hypersensitivity reactions have been thought to be T cell-mediated delayed type hypersensitivity (DTH) reaction. However some of the MM periprosthetic tissues show the presence of B- and plasma cells, as well as massive fibrin exudation, which are not characteristic of a DTH reaction. Therefore, the exact nature of the hypersensitivity reaction(s) MM implants remains unclear. The present study aimed to compare the phenotypes of lymphocytes from the peripheral blood and synovial fluid of patients with failed MM and MPE implants, and from volunteers with no implant (peripheral blood only). Results in peripheral blood showed differences in the T-cell populations depending on the implant type. This included differences in the proportions of T-helper and T-cytotoxic cells, and T-cells expressing IFN-g. Results in synovial fluid showed a significant difference between MM and MPE groups for the B-cells. Both groups depicted a predominance of T-cell lymphocytes in synovial fluid and overall larger proportions of memory cells than in peripheral blood, but group sizes were rather small. Overall, T-cell cytokine expression (analyzed in peripheral blood only because of the limited number of synovial fluid samples) did not exhibit characteristics of a DTH reaction and the proportions of memory lymphocytes did not indicate activation of a specific subset in the MM group. Nevertheless, group sizes still remain to be increased.
|
4 |
Imunologia das interações materno-fetais na asma: padrões de reatividade imunológica no colostro e no sangue de mães asmáticas e no sangue de cordão de seus respectivos recém-nascidos. / Immunology Interaction fetal-maternal in asthma: immunological reactive patterns in blood and colostrum from healthy and asthmatic mothers and in blood from their respective newborns.Silva, Simone Corrêa da 08 April 2008 (has links)
A Asma vem apresentando taxas de prevalência crescentes em todo o mundo. Os objetivos deste trabalho são avaliar a presença de elementos celulares e humorais indicativos em sangue e colostro de mães asmáticas e saudáveis e no sangue de cordão umbilical de seus recém-nascidos (RN). Observamos menor produção de IgG pelas mães asmáticas. Células dendríticas de mães asmáticas possuem maior expressão de CD80 e CD86. Mães asmáticas possuem mais células de memória central. Linfócitos T CD4+ de mães asmáticas produzem níveis maiores IFN-g. Células CD3+ e CD4+ de mães asmáticas produziram mais IL-13. Mães saudáveis produziram maiores quantidades de IL-10. Concluímos que mães asmáticas possuem menores níveis de IgG e IgM, o que parece aumentar dos níveis de IgE, mães asmáticas possuem mais células de memória central, linfócitos T CD4+ produzem maiores quantidades de citocinas como IL-13 e IFN-g, células dendríticas de mães asmáticas possuem maior expressão das moléculas co-estimulatórias, assim como seus RNs possuem maior expressão de CD80. Células de mães asmáticas produzem níveis menores de IL-10, o colostro de mães atópicas não possui diferenças entre os parâmetros aqui estudados. O aleitamento materno deve ser indicado para mães asmáticas e seus filhos. / Asthma has been presenting higher prevalence rates worldwide. The objective of this work is to evaluate the presence of cellular elements and humoral indicative in blood and colostrums of healthy and asthmatic mothers and in cord umbilical blood of their newborn (NB). Lower production of IgG from asthmatic mothers was observed. Dendritic cells of asthmatic mothers have higher CD80 and CD86 expression. Asthmatic mothers have more central memory cells. TCD4+ lymphocyte of asthmatic mothers produce higher levels of IFN-g. CD3+ and CD4+ cells of asthmatic mothers produce higher quantity of IL-13. Healthy mothers produce higher quantity of IL-10. We conclude that asthmatic mothers have lower levels of IgG and IgM, and this seems to raise the IgE levels, asthmatic mothers have more central memory cells, CD4+ T lymphocyte and produce higher quantities of cytokines such as Il-13 and IFN-g. Dendritic cells of asthmatic mothers have higher expression of costimulatory molecules, as well as their NBs have higher expression CD80. Cells of asthmatic mothers produce lower levels of IL-10, the colostrums of atopic mothers does not have differences in the parameters here studied. The maternal breastfeeding must be indicated for asthmatic mothers and their of spring.
|
5 |
Imunologia das interações materno-fetais na asma: padrões de reatividade imunológica no colostro e no sangue de mães asmáticas e no sangue de cordão de seus respectivos recém-nascidos. / Immunology Interaction fetal-maternal in asthma: immunological reactive patterns in blood and colostrum from healthy and asthmatic mothers and in blood from their respective newborns.Simone Corrêa da Silva 08 April 2008 (has links)
A Asma vem apresentando taxas de prevalência crescentes em todo o mundo. Os objetivos deste trabalho são avaliar a presença de elementos celulares e humorais indicativos em sangue e colostro de mães asmáticas e saudáveis e no sangue de cordão umbilical de seus recém-nascidos (RN). Observamos menor produção de IgG pelas mães asmáticas. Células dendríticas de mães asmáticas possuem maior expressão de CD80 e CD86. Mães asmáticas possuem mais células de memória central. Linfócitos T CD4+ de mães asmáticas produzem níveis maiores IFN-g. Células CD3+ e CD4+ de mães asmáticas produziram mais IL-13. Mães saudáveis produziram maiores quantidades de IL-10. Concluímos que mães asmáticas possuem menores níveis de IgG e IgM, o que parece aumentar dos níveis de IgE, mães asmáticas possuem mais células de memória central, linfócitos T CD4+ produzem maiores quantidades de citocinas como IL-13 e IFN-g, células dendríticas de mães asmáticas possuem maior expressão das moléculas co-estimulatórias, assim como seus RNs possuem maior expressão de CD80. Células de mães asmáticas produzem níveis menores de IL-10, o colostro de mães atópicas não possui diferenças entre os parâmetros aqui estudados. O aleitamento materno deve ser indicado para mães asmáticas e seus filhos. / Asthma has been presenting higher prevalence rates worldwide. The objective of this work is to evaluate the presence of cellular elements and humoral indicative in blood and colostrums of healthy and asthmatic mothers and in cord umbilical blood of their newborn (NB). Lower production of IgG from asthmatic mothers was observed. Dendritic cells of asthmatic mothers have higher CD80 and CD86 expression. Asthmatic mothers have more central memory cells. TCD4+ lymphocyte of asthmatic mothers produce higher levels of IFN-g. CD3+ and CD4+ cells of asthmatic mothers produce higher quantity of IL-13. Healthy mothers produce higher quantity of IL-10. We conclude that asthmatic mothers have lower levels of IgG and IgM, and this seems to raise the IgE levels, asthmatic mothers have more central memory cells, CD4+ T lymphocyte and produce higher quantities of cytokines such as Il-13 and IFN-g. Dendritic cells of asthmatic mothers have higher expression of costimulatory molecules, as well as their NBs have higher expression CD80. Cells of asthmatic mothers produce lower levels of IL-10, the colostrums of atopic mothers does not have differences in the parameters here studied. The maternal breastfeeding must be indicated for asthmatic mothers and their of spring.
|
6 |
Estudo da expressão imunoistoquímica de marcadores de resistência a múltiplas drogas em cães com linfoma cutâneo / Study of the immunohistochemical expression of multiple drug resistance markers in dogs with cutaneous lymphomaAlves, Ana Luiza Nairismagi 28 August 2017 (has links)
Linfomas pertencem a um grupo de neoplasias em que há proliferação monoclonal de linfócitos malignos, sendo uma das neoplasias mais frequentemente diagnosticadas em cães. Podem ser classificados quanto à forma anatômica em multicêntrico, mediastinal, digestório e extranodal. Dentre os extranodais, os linfomas cutâneos são classificados histologicamente como epiteliotrópicos e não epiteliotrópicos e são predominantemente de imunfenótipo T, com raros casos do tipo B. A principal característica histopatológica do linfoma epiteliotrópico em cães é o tropismo das células neoplásicas pela epiderme, mucosa ou estruturas anexas, enquanto o linfoma não epiteliotrópico é caracterizado pela infiltração dérmica e subcutânea sem invasão das estruturas anexas. Os linfomas cutâneos caninos têm progressão rápida, são considerados bastante agressivos e com mau prognóstico, com baixa taxa de resposta à quimioterapia. Um dos fatores que podem contribuir para isso é a resistência das células a múltiplas drogas e entre esses mecanismos de resistência estão o efluxo de drogas do meio intracelular para o extracelular por meio dos transportadores da família ABC, como a glicoproteína-P, MRP (multiple resistance protein) e BCRP (breast câncer resistance protein) e da LRP (lung resistance protein), uma proteína vault responsável pelo transporte nucleocitoplasmático. O objetivo deste estudo foi caracterizar imunofenotipicamente os linfomas cutâneos, a proliferação celular por meio do marcador Ki67, a expressão das proteínas de resistência glicoproteína-P, MRP, BCRP e LRP e avaliar a relação dessas proteínas com a sobrevida dos animais. Foi realizado um estudo retrospectivo com 21 casos de cães linfomas cutâneos com diagnóstico histopatológico. A técnica de imunoistoquímica foi utilizada para determinar a imunofenotipagem dos linfomas pelos marcadores CD3 e CD20, a proliferação celular por Ki67 e a expressão de glicoproteína-P, MRP, BCRP e LRP. Dos 21 animais, 38% tiveram diagnóstico histopatológico de linfoma epiteliotrópico, 52% eram linfomas não epiteliotrópicos, 5% dos casos de linfoma não tiveram epiteliotropismo definido e 5% foram classificados como neoplasia de células redondas. O imunofenótipo predominante foi CD3+CD20- (76%), 15% dos casos eram CD3-CD20+ e 9% eram CD3+CD20+. A mediana de células marcadas para Ki67 foi de 31%. Com relação aos marcadores de resistência a múltiplas drogas, a mediana da marcação de glicoproteína-P foi de 40%, a de LRP foi de 65% enquanto para MRP e BCRP, 19% e 23%, respectivamente. Os linfomas cutâneos não epiteliotrópicos foram mais frequentes que os epiteliotrópicos e o imunfenótipo predominante foi o T. A ocorrência de linfócitos CD3-CD20+ e CD3+CD20+ indica a necessidade de mais estudos e um painel mais amplo de anticorpos para subtipagem desses linfomas. A glicoproteína-P teve maior expressão nos linfomas não epiteliotrópicos do que nos epiteliotrópicos e não houve correlação entre as proteínas de resistência e o tempo de sobrevida dos animais, sugerindo que, além da biologia da neoplasia, outros mecanismos de resistência a múltiplas drogas diferente dos estudados possam ter um papel relevante na baixa resposta do linfoma cutâneo à quimioterapia. / Lymphoma is a group of blood cell tumors that develop from monoclonal proliferation of malignant lymphocytes. Lymphoma is the most frequent neoplasia in dogs and can be anatomically classified in multicentric, mediastinal, digestive and extranodal. Cutaneous lymphomas an extranodal type of lymphoma are classified histologically in epitheliotropic and non-epitheliotropic and are predominantly of T-cell immunophenotype, and rare cases of B cell phenotype. The main histopathological characteristic of epitheliotropic lymphoma in dogs is the tropism of neoplastic cells by the epidermis, mucosa or adjacent structures, while non-epitheliotropic lymphoma is characterized by dermal and subcutaneous infiltration without invasion of adjacent structures. Canine cutaneous lymphomas have rapid progression, are considered very aggressive and have poor prognosis. These dogs, usually have a low rate of response to chemotherapy which can be associated to an antineoplastic resistance. Among mechanisms of resistance are efflux of drugs from intracellular to extracellular through ABC family transporters such as P-glycoprotein, MRP (multple resistance protein) and BCRP (breast cancer resistance protein) and LRP (lung resistance protein), a vault protein responsible for nucleocytoplasmic transport. The aim of this study was to characterize immunophenotypically cutaneous lymphomas, measure cell proliferation using the Ki67 marker, the expression of resistance proteins P-glycoprotein, MRP, BCRP and LRP and to evaluate the relationship of these proteins with the survival of the animals. A retrospective study was performed with 21 cases of dogs with cutaneous lymphoma with histopathological diagnosis. Immunohistochemical was used to immunophenotyping of lymphomas by CD3 and CD20 markers, Ki67 cell proliferation, and P-glycoprotein, MRP, BCRP and LRP expression. Of the 21 animals, 38% had histopathological diagnosis of epitheliotropic lymphoma, 52% were non-epitheliotropic lymphomas, 5% of lymphoma cases had no definition and 5% were classified as round cell neoplasia. The predominant immunophenotype was CD3+CD20- (76%), 15% of the cases were CD3-CD20 + and 9% were CD3 + CD20 +. The median of cells labeled for Ki67 was 31%. Regarding the markers of resistance to multiple drugs, the median of the P-glycoprotein label was 40%, which 65% of LRP while for MRP and BCRP, 19% and 23%, respectively. Non-epitheliotropic cutaneous lymphomas were more frequent than epitheliotropic lymphomas and the predominant immunophenotype was T. The occurrence of CD3-CD20+ and CD3+CD20+ lymphocytes indicates the need for further studies and a wider panel of antibodies for subtyping these lymphomas. P-glycoprotein had higher expression in non-epitheliotropic lymphomas than in epitheliotropic lymphomas and there was no correlation between resistance proteins and survival time of the animals, suggesting that in addition to the biology of neoplasia other mechanisms of resistance to multiple drugs different from those studied may play a relevant role in the low response of cutaneous lymphoma to chemotherapy.
|
7 |
Estudo da expressão imunoistoquímica de marcadores de resistência a múltiplas drogas em cães com linfoma cutâneo / Study of the immunohistochemical expression of multiple drug resistance markers in dogs with cutaneous lymphomaAna Luiza Nairismagi Alves 28 August 2017 (has links)
Linfomas pertencem a um grupo de neoplasias em que há proliferação monoclonal de linfócitos malignos, sendo uma das neoplasias mais frequentemente diagnosticadas em cães. Podem ser classificados quanto à forma anatômica em multicêntrico, mediastinal, digestório e extranodal. Dentre os extranodais, os linfomas cutâneos são classificados histologicamente como epiteliotrópicos e não epiteliotrópicos e são predominantemente de imunfenótipo T, com raros casos do tipo B. A principal característica histopatológica do linfoma epiteliotrópico em cães é o tropismo das células neoplásicas pela epiderme, mucosa ou estruturas anexas, enquanto o linfoma não epiteliotrópico é caracterizado pela infiltração dérmica e subcutânea sem invasão das estruturas anexas. Os linfomas cutâneos caninos têm progressão rápida, são considerados bastante agressivos e com mau prognóstico, com baixa taxa de resposta à quimioterapia. Um dos fatores que podem contribuir para isso é a resistência das células a múltiplas drogas e entre esses mecanismos de resistência estão o efluxo de drogas do meio intracelular para o extracelular por meio dos transportadores da família ABC, como a glicoproteína-P, MRP (multiple resistance protein) e BCRP (breast câncer resistance protein) e da LRP (lung resistance protein), uma proteína vault responsável pelo transporte nucleocitoplasmático. O objetivo deste estudo foi caracterizar imunofenotipicamente os linfomas cutâneos, a proliferação celular por meio do marcador Ki67, a expressão das proteínas de resistência glicoproteína-P, MRP, BCRP e LRP e avaliar a relação dessas proteínas com a sobrevida dos animais. Foi realizado um estudo retrospectivo com 21 casos de cães linfomas cutâneos com diagnóstico histopatológico. A técnica de imunoistoquímica foi utilizada para determinar a imunofenotipagem dos linfomas pelos marcadores CD3 e CD20, a proliferação celular por Ki67 e a expressão de glicoproteína-P, MRP, BCRP e LRP. Dos 21 animais, 38% tiveram diagnóstico histopatológico de linfoma epiteliotrópico, 52% eram linfomas não epiteliotrópicos, 5% dos casos de linfoma não tiveram epiteliotropismo definido e 5% foram classificados como neoplasia de células redondas. O imunofenótipo predominante foi CD3+CD20- (76%), 15% dos casos eram CD3-CD20+ e 9% eram CD3+CD20+. A mediana de células marcadas para Ki67 foi de 31%. Com relação aos marcadores de resistência a múltiplas drogas, a mediana da marcação de glicoproteína-P foi de 40%, a de LRP foi de 65% enquanto para MRP e BCRP, 19% e 23%, respectivamente. Os linfomas cutâneos não epiteliotrópicos foram mais frequentes que os epiteliotrópicos e o imunfenótipo predominante foi o T. A ocorrência de linfócitos CD3-CD20+ e CD3+CD20+ indica a necessidade de mais estudos e um painel mais amplo de anticorpos para subtipagem desses linfomas. A glicoproteína-P teve maior expressão nos linfomas não epiteliotrópicos do que nos epiteliotrópicos e não houve correlação entre as proteínas de resistência e o tempo de sobrevida dos animais, sugerindo que, além da biologia da neoplasia, outros mecanismos de resistência a múltiplas drogas diferente dos estudados possam ter um papel relevante na baixa resposta do linfoma cutâneo à quimioterapia. / Lymphoma is a group of blood cell tumors that develop from monoclonal proliferation of malignant lymphocytes. Lymphoma is the most frequent neoplasia in dogs and can be anatomically classified in multicentric, mediastinal, digestive and extranodal. Cutaneous lymphomas an extranodal type of lymphoma are classified histologically in epitheliotropic and non-epitheliotropic and are predominantly of T-cell immunophenotype, and rare cases of B cell phenotype. The main histopathological characteristic of epitheliotropic lymphoma in dogs is the tropism of neoplastic cells by the epidermis, mucosa or adjacent structures, while non-epitheliotropic lymphoma is characterized by dermal and subcutaneous infiltration without invasion of adjacent structures. Canine cutaneous lymphomas have rapid progression, are considered very aggressive and have poor prognosis. These dogs, usually have a low rate of response to chemotherapy which can be associated to an antineoplastic resistance. Among mechanisms of resistance are efflux of drugs from intracellular to extracellular through ABC family transporters such as P-glycoprotein, MRP (multple resistance protein) and BCRP (breast cancer resistance protein) and LRP (lung resistance protein), a vault protein responsible for nucleocytoplasmic transport. The aim of this study was to characterize immunophenotypically cutaneous lymphomas, measure cell proliferation using the Ki67 marker, the expression of resistance proteins P-glycoprotein, MRP, BCRP and LRP and to evaluate the relationship of these proteins with the survival of the animals. A retrospective study was performed with 21 cases of dogs with cutaneous lymphoma with histopathological diagnosis. Immunohistochemical was used to immunophenotyping of lymphomas by CD3 and CD20 markers, Ki67 cell proliferation, and P-glycoprotein, MRP, BCRP and LRP expression. Of the 21 animals, 38% had histopathological diagnosis of epitheliotropic lymphoma, 52% were non-epitheliotropic lymphomas, 5% of lymphoma cases had no definition and 5% were classified as round cell neoplasia. The predominant immunophenotype was CD3+CD20- (76%), 15% of the cases were CD3-CD20 + and 9% were CD3 + CD20 +. The median of cells labeled for Ki67 was 31%. Regarding the markers of resistance to multiple drugs, the median of the P-glycoprotein label was 40%, which 65% of LRP while for MRP and BCRP, 19% and 23%, respectively. Non-epitheliotropic cutaneous lymphomas were more frequent than epitheliotropic lymphomas and the predominant immunophenotype was T. The occurrence of CD3-CD20+ and CD3+CD20+ lymphocytes indicates the need for further studies and a wider panel of antibodies for subtyping these lymphomas. P-glycoprotein had higher expression in non-epitheliotropic lymphomas than in epitheliotropic lymphomas and there was no correlation between resistance proteins and survival time of the animals, suggesting that in addition to the biology of neoplasia other mechanisms of resistance to multiple drugs different from those studied may play a relevant role in the low response of cutaneous lymphoma to chemotherapy.
|
8 |
Imunofenotyp maligních buněk dětských akutních leukemií a jeho vývoj v průběhu onemocnění / Leukaemia associated immunophenotype in childhood acute leukaemias and its development during the course of diseasePodolská, Tereza January 2020 (has links)
Acute lymphoblastic leukaemia (ALL) is the most frequent childhood malignancy. One of the recent improvements in ALL treatment was the introduction of minimal residual disease (MRD) monitoring that enables risk stratification based treatment adaptation. The same MRD monitoring helps to choose relapse treatment, to guide indication for stem cell transplantation (SCT) and allows for a more personalized management of patients undergoing SCT. One of the main routes of MRD levels detection is characterisation of leukemic blasts using flow cytometry. However, flow cytometry is limited by its mainly manual expertise-based analysis. Such analysis is subjective and clearly insufficient for current complex data. While new computational tools are available for multidimensional flow cytometry data, there is an urgent need to test and adapt them for the use in clinical environment. The goal of this thesis is to detect immunophenotypes associated with leukaemia and their development by leveraging machine-assisted analysis of a set of diagnostic files selected based on information about more than three hundred thousand of multiparameter flow cytometry datasets. Advanced bioinformatic tools will help to detect blast and healthy haematopoietic populations, to derive their immunophenotypes and to identify individual...
|
9 |
The inhibitor of differentiation genes expression and association with epithelial-to-mesenchymal markers in phenotypes of breast cancer: an in vitro and clinicopathological studyGarcía-Escolano, Marta 27 September 2019 (has links)
Inhibitor of Differentiation (ID) proteins are a family of four (ID1-4) bHLH transcription factors that lack the DNA binding domain. They act by forming dimers with other transcriptional regulators and inhibiting their interaction with DNA. They play a crucial role during embryonic development and later in the adulthood, their expression is mostly restricted to a few populations of stem cells. In the last decades, many authors have described their re-activation and participation in tumor development, angiogenesis and EMT although the results are still controversial. In the first chapter of this research work, the role of ID genes as prognostic markers in breast cancer was evaluated. We studied the mRNA expression of the four ID genes and four markers of EMT by qRT-PCR in a clinical series of 307 primary breast carcinomas previously stratified in immunophenotypes. In addition, the expression of all these genes was measured in breast cancer cell lines and mammospheres. Overexpression of at least one ID gene was found in 48.9% of the studied samples. ID1 and ID4 were overexpressed mostly in TNBL and HER2-enriched subtypes, whereas ID2 and ID3 were overexpressed more frequently in luminal tumors. High ID1 and ID4 was associated with larger tumor size, histological grade 3, presence of necrosis and vascular invasion, and poorer outcome. Multivariate analysis revealed that ID4 and vascular invasion were independent factors for DFS. Regarding EMT markers, high levels of SNAI1 were associated with the overexpression of the four ID genes. Additionally, ID1 overexpression was positively related to TWIST1, and the overexpression of ID2 and ID3 was more frequently paired with tumors that conserve CHD1 expression. In vitro studies showed high expression of the four ID genes in all cell lines. However, when mammospheres were formed, mRNA levels of ID genes decreased, in contrast to SNAI1 and TWIST1, which mostly increased. In the second chapter of this thesis, we aimed to (a) describe the mechanisms of action of a small molecule pan-ID antagonist, (b) define its main targets and (c) investigate potential pathways of acquire resistance. Treatment with AGX51 led to Id protein loss, increase in ROS accumulation, cell cycle arrest, and cell death in all tumor cell lines tested. Here, we used an antioxidant compound in different cell lines to demonstrate that ROS are the main responsible of cell death following treatment with AGX51. A model of cultured quiescent cells not expressing ID proteins served to show that the main target of AGX51 are these proteins. Experiments with AGX-derivatives also supported these results. Finally, three mutagenizing agents were used in order to generate mutations that confer resistance to treatment with AGX51. Treatment with ENU gave rise to two clones apparently resistant to AGX51 effects. Based on our in vitro and clinicopathological studies, we conclude that ID1 and ID4 may act as biomarkers of worse prognosis in patients with breast cancer, and seem to be involved in the initiation of EMT mechanism. Therefore, they are potential targets for the development of novel drugs. In line with this, AGX51 arises as a potent anti-ID compound that has anticancer effects.
|
10 |
Imunofenotypové rozdíly v B lymfocytárních populacích non-memory B lymfocytů u zdravých kontrol a pacientů s imunopatologiemi. / Immunophenotype differences in non-memory B lymphocyte populations in healthy controls and patients with immunopathologiesPolák, Milan January 2014 (has links)
B-lymphocytes are a subset of immune cells that can be distinguished mainly by carrying clonally diversified membrane-bound immunoglobulin specialized to specific antigen recognition. Together with other immunocytes B-lymphocytes play a central role in adaptive immune system which takes part in defense of the host against wide variety of pathogens. Recently the evidence has supported the emerging concept of different B-cell subpopulations to play a direct or indirect role in a pathogenesis of spectrum of disorders. However, so far the knowledge has been limited mainly in the way of how the specific differentiation stages of B-lymphocytes are involved in pathogenesis of diseases and how course of disease, stage, and eventually different treatment can affect B-cell homeostasis. That is the reason for the thesis to be focused on an analysis of B-cell population profile changes in disease, identification of any association present among specific B-cell subpopulations, as well as association between these subpopulations and clinical parameters. Using polychromatic flow cytometry we analyzed frequencies of 11 B-cell subpopulations including stages of transient B-lymphocytes through effector antibody-producing plasma cells. We examined 81 individuals including 22 healthy controls and 59 patients with...
|
Page generated in 0.0403 seconds